Kailera Therapeutics, Inc.
USD21.67
+0.84 (+4.03%)
CEO
Ronald C. Renaud Jr.
IPO Date
2026-04-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$20.85
Prev. Close
$20.83
Day Low
$20.85
Day High
$21.88
52W Low
$18.50
52W High
$28.23
Market Cap
$2.81B
Volume
0.58M
| 38,094 |
| $5.25 |
| 22 Apr 2026 | RTW INVESTMENTS, LP | 10 percent owner | C-Conversion | Acquired | 10,276,820 | $0.00 |
| 22 Apr 2026 | RTW INVESTMENTS, LP | 10 percent owner | P-Purchase | Acquired | 500,000 | $16.00 |
| 22 Apr 2026 | RTW INVESTMENTS, LP | 10 percent owner | C-Conversion | Disposed | 8,250,000 | $0.00 |
| 22 Apr 2026 | RTW INVESTMENTS, LP | 10 percent owner | C-Conversion | Disposed | 2,026,820 | $0.00 |
| 22 Apr 2026 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 10 percent owner | C-Conversion | Acquired | 9,477,719 | $0.00 |
| 22 Apr 2026 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 10 percent owner | C-Conversion | Acquired | 2,034,133 | $0.00 |
| 22 Apr 2026 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 10 percent owner | C-Conversion | Disposed | 4,968,789 | $0.00 |
| 22 Apr 2026 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 10 percent owner | C-Conversion | Disposed | 708,814 | $0.00 |